Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR

Binding of the Tat protein to TAR RNA is necessary for viral replication of HIV-1. We screened the Available Chemicals Directory (ACD) to identify ligands to bind to a TAR RNA structure using a four-step docking procedure: rigid docking first, followed by three steps of flexible docking using a pseudobrownian Monte Carlo minimization in torsion angle space with progressively more detailed conformational sampling on a progressively smaller list of top-ranking compounds. To validate the procedure, we successfully docked ligands for five RNA complexes of known structure. For ranking ligands according to binding avidity, an empirical binding free energy function was developed which accounts, in particular, for solvation, isomerization free energy, and changes in conformational entropy. System-specific parameters for the function were derived on a training set of RNA/ligand complexes with known structure and affinity. To validate the free energy function, we screened the entire ACD for ligands for an RNA aptamer which binds l-arginine tightly. The native ligand ranked 17 out of ca. 153,000 compounds screened, i.e., the procedure is able to filter out >99.98% of the database and still retain the native ligand. Screening of the ACD for TAR ligands yielded a high rank for all known TAR ligands contained in the ACD and suggested several other potential TAR ligands. Eight of the highest ranking compounds not previously known to be ligands were assayed for inhibition of the Tat-TAR interaction, and two exhibited a CD50 of ca. 1 μM.

[1]  D. Richman,et al.  Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist. , 1991, Science.

[2]  M Sumner-Smith,et al.  Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure , 1992, Journal of virology.

[3]  D A Agard,et al.  Computational method for the design of enzymes with altered substrate specificity. , 1991, Journal of molecular biology.

[4]  B. Sullenger,et al.  Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation , 1991, Journal of virology.

[5]  K. P. Murphy,et al.  Structural energetics of peptide recognition: Angiotensin II/antibody binding , 1993, Proteins.

[6]  B. Peterlin,et al.  Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators , 1992, Journal of virology.

[7]  Ruben Abagyan,et al.  Efficient parallelization of the energy, surface, and derivative calculations for internal coordinate mechanics , 1994, J. Comput. Chem..

[8]  Pieter F. W. Stouten,et al.  A molecular mechanics/grid method for evaluation of ligand–receptor interactions , 1995, J. Comput. Chem..

[9]  Hans-Joachim Böhm,et al.  Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programs , 1998, J. Comput. Aided Mol. Des..

[10]  Randy J. Read,et al.  A multiple‐start Monte Carlo docking method , 1992 .

[11]  Kevin P. Clark,et al.  Flexible ligand docking without parameter adjustment across four ligand–receptor complexes , 1995, J. Comput. Chem..

[12]  M. Mizutani,et al.  Rational automatic search method for stable docking models of protein and ligand. , 1994, Journal of molecular biology.

[13]  J. Karn,et al.  The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. , 1995, Journal of molecular biology.

[14]  Y Wang,et al.  RNA molecules that specifically and stoichiometrically bind aminoglycoside antibiotics with high affinities. , 1996, Biochemistry.

[15]  I D Kuntz,et al.  Structure-based discovery of ligands targeted to the RNA double helix. , 1997, Biochemistry.

[16]  D K Gehlhaar,et al.  De novo design of enzyme inhibitors by Monte Carlo ligand generation. , 1995, Journal of medicinal chemistry.

[17]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[18]  D M Crothers,et al.  Fragments of the HIV-1 Tat protein specifically bind TAR RNA. , 1990, Science.

[19]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[20]  M J Sternberg,et al.  Empirical scale of side-chain conformational entropy in protein folding. , 1993, Journal of molecular biology.

[21]  M C Hsu,et al.  The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter , 1995, Journal of virology.

[22]  J T Finch,et al.  RNA binding by the tat and rev proteins of HIV-1. , 1991, Biochimie.

[23]  F. Young Biochemistry , 1955, The Indian Medical Gazette.

[24]  J. Puglisi,et al.  Conformation of the TAR RNA-arginine complex by NMR spectroscopy. , 1992, Science.

[25]  T R Bailey,et al.  Keto/enol epoxy steroids: a new structural class of HIV-1 Tat inhibitors. , 1993, Journal of medicinal chemistry.

[26]  S Vajda,et al.  Effect of conformational flexibility and solvation on receptor-ligand binding free energies. , 1994, Biochemistry.

[27]  P. Sharp,et al.  HIV‐1 Tat protein promotes formation of more‐processive elongation complexes. , 1991, The EMBO journal.

[28]  P. Weiner,et al.  Computer Simulation of Biomolecular Systems , 1997 .

[29]  Anton V. Filikov,et al.  Structure-based design of ligands for protein basic domains: Application to the HIV-1 Tat protein , 1998, J. Comput. Aided Mol. Des..

[30]  T. James,et al.  Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA. , 1996, Journal of biomolecular structure & dynamics.

[31]  A Caflisch,et al.  Monte carlo minimization with thermalization for global optimization of polypeptide conformations in cartesian coordinate space , 1992, Proteins.

[32]  J. Vos,et al.  Dating Hominid Sites in Indonesia , 1994 .

[33]  B Tidor,et al.  Arginine-mediated RNA recognition: the arginine fork , 1991, Science.

[34]  I. Kuntz,et al.  Automated docking with grid‐based energy evaluation , 1992 .

[35]  P. Luciw,et al.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product , 1987, Nature.

[36]  Wilfred F. van Gunsteren,et al.  Computer Simulation of Biomolecular Systems: Theoretical and Experimental Applications , 1989 .

[37]  Ruben Abagyan,et al.  ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..

[38]  H J Berendsen,et al.  Molecular dynamics simulation of the docking of substrates to proteins , 1994, Proteins.

[39]  D. Patel,et al.  Saccharide-RNA recognition in an aminoglycoside antibiotic-RNA aptamer complex. , 1997, Chemistry & biology.

[40]  J. Karn,et al.  Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. , 1996, Nucleic acids research.

[41]  J. Puglisi,et al.  Solution Structure of a Bovine Immunodeficiency Virus Tat-TAR Peptide-RNA Complex , 1995, Science.

[42]  P Argos,et al.  Optimal protocol and trajectory visualization for conformational searches of peptides and proteins. , 1992, Journal of molecular biology.

[43]  R. Bruccoleri,et al.  On the attribution of binding energy in antigen-antibody complexes McPC 603, D1.3, and HyHEL-5. , 1989, Biochemistry.

[44]  D F Hoth,et al.  Present status and future prospects for HIV therapies. , 1993, Science.

[45]  D. Patel,et al.  Molecular recognition in the FMN-RNA aptamer complex. , 1996, Journal of molecular biology.

[46]  Johan Desmet,et al.  The dead-end elimination theorem and its use in protein side-chain positioning , 1992, Nature.

[47]  D. Ecker,et al.  Pseudo--half-knot formation with RNA. , 1992, Science.

[48]  E Westhof,et al.  Structural Basis of Ligand Discrimination by Two Related RNA Aptamers Resolved by NMR Spectroscopy , 1996, Science.

[49]  H. Scheraga,et al.  Energy parameters in polypeptides. VII. Geometric parameters, partial atomic charges, nonbonded interactions, hydrogen bond interactions, and intrinsic torsional potentials for the naturally occurring amino acids , 1975 .

[50]  I. Kuntz,et al.  Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. , 1988, Journal of medicinal chemistry.

[51]  J. Scott Dixon,et al.  Flexible ligand docking using a genetic algorithm , 1995, J. Comput. Aided Mol. Des..

[52]  I. Kuntz,et al.  Conformational analysis of flexible ligands in macromolecular receptor sites , 1992 .

[53]  M. Malim,et al.  Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein , 1989, Journal of virology.